The HPA - immune axis and the immunomodulatory actions of glucocorticoids in the brain

Frontiers in Immunology

Volumn 5, Issue MAR, 2014, Pages

  Bellavance, Marc André ^a   Rivest, Serge ^a  

^a Université Laval   (Canada)

Author keywords

Glucocorticoid receptor; Glucocorticoids; HPA axis; Inflammation; Microglia; Stress

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

BLOOD BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; BRAIN REGION; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS;

EID: 84987849913     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00136     Document Type: Review

References (163)

1. Lowry CA. Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol (2002) 14(11):911-23. doi:10.1046/j.1365-2826.2002.00861.x
2. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci (2009) 10(6):397-409. doi:10.1038/nrn2647
3. Zhang Y, Damjanoska KJ, Carrasco GA, Dudas B, D'Souza DN, Tetzlaff J, et al. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J Neurosci (2002) 22(21):9635-42.
4. Aguilera G. HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol (2011) 46(2-3):90-5. doi:10.1016/j.exger.2010.08.023
5. Howell MP, Muglia LJ. Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice. Front Neuroendocrinol (2006) 27(3):275-84. doi:10.1016/j.yfrne.2006.05.001
6. Turrin NP, Rivest S. Molecular and cellular immune mediators of neuroprotection. Mol Neurobiol (2006) 34(3):221-42. doi:10.1385/MN:34:3:221
7. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol (2002) 20:125-63. doi:10.1146/annurev.immunol.20.082401.104914
8. Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci (2010) 11(10):710-8. doi:10.1038/nrn2914
9. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature (2002) 418(6901):935-41. doi:10.1038/nature00965
10. Stavreva DA, Wiench M, John S, Conway-Campbell BL, McKenna MA, Pooley JR, et al. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol (2009) 11(9):1093-102. doi:10.1038/ncb1922
11. de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci (2005) 6(6):463-75. doi:10.1038/nrn1683
12. Lupien SJ, Mcewen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci (2009) 10(6):434-45. doi:10.1038/nrn2639
13. Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD. Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress. Endocrinology (1998) 139(2):443-50. doi:10.1210/en.139.2.443
14. Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther (2011) 130(2):226-38. doi:10.1016/j.pharmthera.2011.01.014
15. Turrin NP, Rivest S. Unraveling the molecular details involved in the intimate link between the immune and neuroendocrine systems. Exp Biol Med (Maywood) (2004) 229(10):996-1006.
16. Gosselin D, Rivest S. MyD88 signaling in brain endothelial cells is essential for the neuronal activity and glucocorticoid release during systemic inflammation. Mol Psychiatry (2008) 13(5):480-97. doi:10.1038/sj.mp.4002122
17. Serrats J, Schiltz JC, García-Bueno B, van Rooijen N, Reyes TM, Sawchenko PE. Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron (2010) 65(1):94-106. doi:10.1016/j.neuron.2009.11.032
18. Elander L, Engstrom L, Ruud J, Mackerlova L, Jakobsson PJ, Engblom D, et al. Inducible prostaglandin E2 synthesis interacts in a temporally supplementary sequence with constitutive prostaglandin-synthesizing enzymes in creating the hypothalamic-pituitary-adrenal axis response to immune challenge. J Neurosci (2009) 29(5):1404-13. doi:10.1523/JNEUROSCI.5247-08.2009
19. García-Bueno B, Serrats J, Sawchenko PE. Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. J Neurosci (2009) 29(41):12970-81. doi:10.1523/JNEUROSCI.2373-09.2009
20. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol (2006) 6(4):318-28. doi:10.1038/nri1810
21. Tracey KJ. Reflex control of immunity. Nat Rev Immunol (2009) 9(6):418-28. doi:10.1038/nri2566
22. Kleiman A, Tuckermann JP. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Mol Cell Endocrinol (2007) 275(1-2):98-108. doi:10.1016/j.mce.2007.05.009
23. Bertini R, Bianchi M, Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med (1988) 167(5):1708-12. doi:10.1084/jem.167.5.1708
24. Edwards CK, Yunger LM, Lorence RM, Dantzer R, Kelley KW. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc Natl Acad Sci U S A (1991) 88(6):2274-7. doi:10.1073/pnas.88.6.2274
25. MacPhee IA, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med (1989) 169(2):431-45. doi:10.1084/jem.169.2.431
26. Ramachandra RN, Sehon AH, Berczi I. Neuro-hormonal host defence in endotoxin shock. Brain Behav Immun (1992) 6(2):157-69. doi:10.1016/0889-1591(92)90015-G
27. Ruzek MC, Pearce BD, Miller AH, Biron CA. Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J Immunol (1999) 162(6):3527-33.
28. Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT, et al. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci (2011) 31(29):10506-15. doi:10.1523/JNEUROSCI.0496-11.2011
29. Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci (2013) 34(9):518-30. doi:10.1016/j.tips.2013.07.003
30. Vandevyver S, Dejager L, Tuckermann J, Libert C. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology (2013) 154(3):993-1007. doi:10.1210/en.2012-2045
31. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 101(4):890-8. doi:10.1172/JCI1112
32. Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 162(6):3639-46.
33. Franchimont D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann N Y Acad Sci (2004) 1024:124-37. doi:10.1196/annals.1321.009
34. Ehrchen J, Steinmüller L, Barczyk K, Tenbrock K, Nacken W, Eisenacher M, et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood (2007) 109(3):1265-74. doi:10.1182/blood-2006-02-001115
35. Vallelian F, Schaer CA, Kaempfer T, Gehrig P, Duerst E, Schoedon G, et al. Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity. Blood (2010) 116(24):5347-56. doi:10.1182/blood-2010-04-277319
36. Elftman MD, Norbury CC, Bonneau RH, Truckenmiller ME. Corticosterone impairs dendritic cell maturation and function. Immunology (2007) 122(2):279-90. doi:10.1111/j.1365-2567.2007.02637.x
37. Hontelez S, Karthaus N, Looman MW, Ansems M, Adema GJ. DC-SCRIPT regulates glucocorticoid receptor function and expression of its target GILZ in dendritic cells. J Immunol (2013) 190(7):3172-9. doi:10.4049/jimmunol.1201776
38. Luther C, Adamopoulou E, Stoeckle C, Brucklacher-Waldert V, Rosenkranz D, Stoltze L, et al. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J Immunol (2009) 183(2):841-8. doi:10.4049/jimmunol.0802046
39. Rutella S, Lemoli RM. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol Lett (2004) 94(1-2):11-26. doi:10.1016/j.imlet.2004.04.015
40. Cohen N, Mouly E, Hamdi H, Maillot MC, Pallardy M, Godot V, et al. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood (2006) 107(5):2037-44. doi:10.1182/blood-2005-07-2760
41. Hamdi H, Godot V, Maillot MC, Prejean MV, Cohen N, Krzysiek R, et al. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood (2007) 110(1):211-9. doi:10.1182/blood-2006-10-052506
42. Cao Y, Bender IK, Konstantinidis AK, Shin SC, Jewell CM, Cidlowski JA, et al. Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans. Blood (2013) 121(9):1553-62. doi:10.1182/blood-2012-05-432336
43. Busillo JM, Azzam KM, Cidlowski JA. Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J Biol Chem (2011) 286(44):38703-13. doi:10.1074/jbc.M111.275370
44. Weber PS, Toelboell T, Chang LC, Tirrell JD, Saama PM, Smith GW, et al. Mechanisms of glucocorticoid-induced down-regulation of neutrophil L-selectin in cattle: evidence for effects at the gene-expression level and primarily on blood neutrophils. J Leukoc Biol (2004) 75(5):815-27. doi:10.1189/jlb.1003505
45. Vago JP, Nogueira CR, Tavares LP, Soriani FM, Lopes F, Russo RC, et al. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol (2012) 92(2):249-58. doi:10.1189/jlb.0112008
46. p38 mitogen-activated protein kinase regulate induction of Mcl-1 and survival in glucocorticoid-treated human neutrophils. J Allergy Clin Immunol (2008) 121(2):492.e-8.e. doi:10.1016/j.jaci.2007.10.003
47. Besedovsky L, Born J, Lange T. Endogenous glucocorticoid receptor signaling drives rhythmic changes in human T-cell subset numbers and the expression of the chemokine receptor CXCR4. FASEB J (2013) 28(1):67-75. doi:10.1096/fj.13-237958
48. Fischer HJ, Schweingruber N, Lühder F, Reichardt HM. The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Mol Cell Endocrinol (2013) 380(1-2):99-107. doi:10.1016/j.mce.2013.04.001
49. Molitoris JK, McColl KS, Swerdlow S, Matsuyama M, Lam M, Finkel TH, et al. Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes. J Biol Chem (2011) 286(34):30181-9. doi:10.1074/jbc.M111.245423
50. Purton JF, Monk JA, Liddicoat DR, Kyparissoudis K, Sakkal S, Richardson SJ, et al. Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J Immunol (2004) 173(6):3816-24.
51. 4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection. J Exp Med (2013) 210(10):1919-27. doi:10.1084/jem.20122300
52. Wüst S, van den Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, et al. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol (2008) 180(12):8434-43.
53. Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol (2010) 120(2-3):69-75. doi:10.1016/j.jsbmb.2010.03.058
54. Tischner D, Reichardt HM. Glucocorticoids in the control of neuroinflammation. Mol Cell Endocrinol (2007) 275(1-2):62-70. doi:10.1016/j.mce.2007.03.007
55. Löwenberg M, Tuynman J, Bilderbeek J, Gaber T, Buttgereit F, van Deventer S, et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood (2005) 106(5):1703-10. doi:10.1182/blood-2004-12-4790
56. Löwenberg M, Verhaar AP, Bilderbeek J, Marle JV, Buttgereit F, Peppelenbosch MP, et al. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep (2006) 7(10):1023-9. doi:10.1038/sj.embor.7400775
57. Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, et al. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev (2011) 10(6):305-10. doi:10.1016/j.autrev.2010.11.009
58. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci (2007) 8(1):57-69. doi:10.1038/nrn2038
59. Kierdorf K, Prinz M. Factors regulating microglia activation. Front Cell Neurosci (2013) 7:44. doi:10.3389/fncel.2013.00044
60. Rivest S. Regulation of innate immune responses in the brain. Nat Rev Immunol (2009) 9(6):429-39. doi:10.1038/nri2565
61. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci (2005) 8(6):752-8. doi:10.1038/nn1472
62. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (2005) 308(5726):1314-8. doi:10.1126/science.1110647
63. Hellwig S, Heinrich A, Biber K. The brain's best friend: microglial neurotoxicity revisited. Front Cell Neurosci (2013) 7:71. doi:10.3389/fncel.2013.00071
64. Wolf Y, Yona S, Kim KW, Jung S. Microglia, seen from the CX3CR1 angle. Front Cell Neurosci (2013) 7:26. doi:10.3389/fncel.2013.00026
65. Sierra A, Gottfried-Blackmore A, Milner TA, Mcewen BS, Bulloch K. Steroid hormone receptor expression and function in microglia. Glia (2008) 56(6):659-74. doi:10.1002/glia.20644
66. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev (1998) 19(3):269-301. doi:10.1210/edrv.19.3.0331
67. Henley DE, Lightman SL. New insights into corticosteroid-binding globulin and glucocorticoid delivery. Neuroscience (2011) 180:1-8. doi:10.1016/j.neuroscience.2011.02.053
68. Wyrwoll CS, Holmes MC, Seckl JR. 11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol (2011) 32(3):265-86. doi:10.1016/j.yfrne.2010.12.001
69. Gottfried-Blackmore A, Sierra A, Mcewen BS, Ge R, Bulloch K. Microglia express functional 11 beta-hydroxysteroid dehydrogenase type 1. Glia (2010) 58(10):1257-66. doi:10.1002/glia.21007
70. Joëls M, Karst H, DeRijk R, de Kloet ER. The coming out of the brain mineralocorticoid receptor. Trends Neurosci (2008) 31(1):1-7. doi:10.1016/j.tins.2007.10.005
71. Kolber BJ, Wieczorek L, Muglia LJ. Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function. Stress (2008) 11(5):321-38. doi:10.1080/10253890701821081
72. Oakley RH, Cidlowski JA. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem (2011) 286(5):3177-84. doi:10.1074/jbc.R110.179325
73. Beck IM, Vanden Berghe W, Vermeulen L, Yamamoto KR, Haegeman G, De Bosscher K. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev (2009) 30(7):830-82. doi:10.1210/er.2009-0013
74. Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol (2013) 132(5):1033-44. doi:10.1016/j.jaci.2013.09.007
75. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids (2010) 75(1):1-12. doi:10.1016/j.steroids.2009.09.002
76. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol (2008) 4(10):525-33. doi:10.1038/ncprheum0898
77. Taniguchi Y, Iwasaki Y, Tsugita M, Nishiyama M, Taguchi T, Okazaki M, et al. Glucocorticoid receptor-beta and receptor-gamma exert dominant negative effect on gene repression but not on gene induction. Endocrinology (2010) 151(7):3204-13. doi:10.1210/en.2009-1254
78. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA. Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active. Mol Cell Biol (2007) 27(6):2266-82. doi:10.1128/MCB.01439-06
79. Stahn C, Löwenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol (2007) 275(1-2):71-8. doi:10.1016/j.mce.2007.05.019
80. McNally JG, Müller WG, Walker D, Wolford R, Hager GL. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science (2000) 287(5456):1262-5. doi:10.1126/science.287.5456.1262
81. Voss TC, Schiltz RL, Sung MH, Yen PM, Stamatoyannopoulos JA, Biddie SC, et al. Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell (2011) 146(4):544-54. doi:10.1016/j.cell.2011.07.006
82. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med (2006) 203(8):1883-9. doi:10.1084/jem.20060336
83. Bhattacharyya S, Zhao Y, Kay TW, Muglia LJ. Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation. Proc Natl Acad Sci U S A (2011) 108(23):9554-9. doi:10.1073/pnas.1017296108
84. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity (1997) 7(6):803-12. doi:10.1016/S1074-7613(00)80398-2
85. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med (2006) 203(1):131-40. doi:10.1084/jem.20051794
86. Chinenov Y, Rogatsky I. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network. Mol Cell Endocrinol (2007) 275(1-2):30-42. doi:10.1016/j.mce.2007.04.014
87. De Bosscher K, Beck IM, Haegeman G. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system? Brain Behav Immun (2010) 24(7):1035-42. doi:10.1016/j.bbi.2010.06.010
88. Gupte R, Muse GW, Chinenov Y, Adelman K, Rogatsky I. Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle. Proc Natl Acad Sci U S A (2013) 110(36):14616-21. doi:10.1073/pnas.1309898110
89. Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell (2011) 145(2):224-41. doi:10.1016/j.cell.2011.03.027
90. Revollo JR, Oakley RH, Lu NZ, Kadmiel M, Gandhavadi M, Cidlowski JA. HES1 is a master regulator of glucocorticoid receptor-dependent gene expression. Sci Signal (2013) 6(304):ra103. doi:10.1126/scisignal.2004389
91. Almawi WY, Melemedjian OK. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J Mol Endocrinol (2002) 28(2):69-78. doi:10.1677/jme.0.0280069
92. Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol (2010) 120(2-3):76-85. doi:10.1016/j.jsbmb.2010.02.018
93. Flammer JR, Rogatsky I. Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms. Mol Endocrinol (2011) 25(7):1075-86. doi:10.1210/me.2011-0068
94. Reily MM, Pantoja C, Hu X, Chinenov Y, Rogatsky I. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J (2006) 25(1):108-17. doi:10.1038/sj.emboj.7600919
95. Wolf IM, Periyasamy S, Hinds T, Yong W, Shou W, Sanchez ER. Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol (2009) 113(1-2):36-45. doi:10.1016/j.jsbmb.2008.11.006
96. Groeneweg FL, Karst H, de Kloet ER, Joëls M. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol Cell Endocrinol (2012) 350(2):299-309. doi:10.1016/j.mce.2011.06.020
97. Haller J, Mikics E, Makara GB. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol (2008) 29(2):273-91. doi:10.1016/j.yfrne.2007.10.004
98. Strehl C, Gaber T, Löwenberg M, Hommes DW, Verhaar AP, Schellmann S, et al. Origin and functional activity of the membrane-bound glucocorticoid receptor. Arthritis Rheum (2011) 63(12):3779-88. doi:10.1002/art.30637
99. Bartholome B, Spies CM, Gaber T, Schuchmann S, Berki T, Kunkel D, et al. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J (2004) 18(1):70-80. doi:10.1096/fj.03-0328com
100. Samarasinghe RA, Di Maio R, Volonte D, Galbiati F, Lewis M, Romero G, et al. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci U S A (2011) 108(40):16657-62. doi:10.1073/pnas.1102821108
101. Löwenberg M, Verhaar AP, van den Brink GR, Hommes DW. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med (2007) 13(4):158-63. doi:10.1016/j.molmed.2007.02.001
102. Ghosh MC, Baatar D, Collins G, Carter A, Indig F, Biragyn A, et al. Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck. Blood (2009) 113(3):575-84. doi:10.1182/blood-2008-04-151803
103. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol Rev (2000) 52(4):513-56.
104. Van Laethem F, Liang X, Andris F, Urbain J, Vandenbranden M, Ruysschaert JM, et al. Glucocorticoids alter the lipid and protein composition of membrane rafts of a murine T cell hybridoma. J Immunol (2003) 170(6):2932-9.
105. Yamagata S, Tomita K, Sano H, Itoh Y, Fukai Y, Okimoto N, et al. Non-genomic inhibitory effect of glucocorticoids on activated peripheral blood basophils through suppression of lipid raft formation. Clin Exp Immunol (2012) 170(1):86-93. doi:10.1111/j.1365-2249.2012.04636.x
106. Beck IM, De Bosscher K, Haegeman G. Glucocorticoid receptor mutants: man-made tools for functional research. Trends Endocrinol Metab (2011) 22(8):295-310. doi:10.1016/j.tem.2011.03.009
107. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell (1998) 93(4):531-41. doi:10.1016/S0092-8674(00)81183-6
108. Tuckermann JP, Reichardt HM, Arribas R, Richter KH, Schütz G, Angel P. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J Cell Biol (1999) 147(7):1365-70. doi:10.1083/jcb.147.7.1365
109. Kleiman A, Hübner S, Rodriguez Parkitna JM, Neumann A, Hofer S, Weigand MA, et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J (2012) 26(2):722-9. doi:10.1096/fj.11-192112
110. Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest (2007) 117(5):1381-90. doi:10.1172/JCI28034
111. Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, et al. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci U S A (2003) 100(24):13845-50. doi:10.1073/pnas.2336092100
112. Adams M, Meijer OC, Wang J, Bhargava A, Pearce D. Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants. Mol Endocrinol (2003) 17(12):2583-92. doi:10.1210/me.2002-0305
113. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood (2007) 109(10):4313-9. doi:10.1182/blood-2006-10-048215
114. Silverman MN, Mukhopadhyay P, Belyavskaya E, Tonelli LH, Revenis BD, Doran JH, et al. Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice. Mol Psychiatry (2013) 18(9):1006-17. doi:10.1038/mp.2012.131
115. Ros-Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol J-C, Lu L, et al. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A (2011) 108:6632-7. doi:10.1073/pnas.1017820108
116. Carrillo-de Sauvage Má, Maatouk L, Arnoux I, Pasco M, Sanz Diez A, Delahaye M, et al. Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation. Cell Death Differ (2013) 20(11):1546-57. doi:10.1038/cdd.2013.108
117. Sorrells SF, Caso JR, Munhoz CD, Hu CK, Tran KV, Miguel ZD, et al. Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation. J Neurosci (2013) 33(18):7877-89. doi:10.1523/JNEUROSCI.4705-12.2013
118. Goodwin JE, Feng Y, Velazquez H, Sessa WC. Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S A (2013) 110(1):306-11. doi:10.1073/pnas.1210200110
119. Boyle MP, Brewer JA, Funatsu M, Wozniak DF, Tsien JZ, Izumi Y, et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci U S A (2005) 102(2):473-8. doi:10.1073/pnas.0406458102
120. Jeanneteau FD, Lambert WM, Ismaili N, Bath KG, Lee FS, Garabedian MJ, et al. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc Natl Acad Sci U S A (2012) 109(4):1305-10. doi:10.1073/pnas.1114122109
121. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med (2005) 353(16):1711-23. doi:10.1056/NEJMra050541
122. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell (2005) 122(5):707-21. doi:10.1016/j.cell.2005.06.029
123. McCoy CE, Carpenter S, Pålsson-McDermott EM, Gearing LJ, O'Neill LA. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and-4 by targeting TBK1 activation. J Biol Chem (2008) 283(21):14277-85. doi:10.1074/jbc.M709731200
124. Bhattacharyya S, Ratajczak CK, Vogt SK, Kelley C, Colonna M, Schreiber RD, et al. TAK1 targeting by glucocorticoids determines JNK and IkappaB regulation in Toll-like receptor-stimulated macrophages. Blood (2010) 115(10):1921-31. doi:10.1182/blood-2009-06-224782
125. Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science (2009) 324(5925):407-10. doi:10.1126/science.1164265
126. van Tilborg MA, Lefstin JA, Kruiskamp M, Teuben J, Boelens R, Yamamoto KR, et al. Mutations in the glucocorticoid receptor DNA-binding domain mimic an allosteric effect of DNA. J Mol Biol (2000) 301(4):947-58. doi:10.1006/jmbi.2000.4001
127. Butler LD, Layman NK, Riedl PE, Cain RL, Shellhaas J, Evans GF, et al. Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha. J Neuroimmunol (1989) 24(1-2):143-53. doi:10.1016/0165-5728(89)90108-2
128. Goujon E, Parnet P, Cremona S, Dantzer R. Endogenous glucocorticoids down regulate central effects of interleukin-1 beta on body temperature and behaviour in mice. Brain Res (1995) 702(1-2):173-80. doi:10.1016/0006-8993(95)01041-9
129. Goujon E, Parnet P, Layé S, Combe C, Dantzer R. Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Brain Res Mol Brain Res (1996) 36(1):53-62. doi:10.1016/0169-328X(95)00242-K
130. Masferrer JL, Seibert K, Zweifel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci U S A (1992) 89(9):3917-21. doi:10.1073/pnas.89.9.3917
131. Drew PD, Chavis JA. Inhibition of microglial cell activation by cortisol. Brain Res Bull (2000) 52(5):391-6. doi:10.1016/S0361-9230(00)00275-6
132. Tanaka J, Fujita H, Matsuda S, Toku K, Sakanaka M, Maeda N. Glucocorticoid-and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. Glia (1997) 20(1):23-37. doi:10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.3.CO;2-U
133. Glezer I, Munhoz CD, Kawamoto EM, Marcourakis T, Avellar MC, Scavone C. MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS. Neuropharmacology (2003) 45(8):1120-9. doi:10.1016/S0028-3908(03)00279-X
134. Munhoz CD, Sorrells SF, Caso JR, Scavone C, Sapolsky RM. Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner. J Neurosci (2010) 30(41):13690-8. doi:10.1523/JNEUROSCI.0303-09.2010
135. Blais V, Zhang J, Rivest S. In altering the release of glucocorticoids, ketorolac exacerbates the effects of systemic immune stimuli on expression of proinflammatory genes in the brain. Endocrinology (2002) 143(12):4820-7. doi:10.1210/en.2002-220598
136. Blais V, Turrin NP, Rivest S. Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli. J Neurochem (2005) 95(6):1563-74. doi:10.1111/j.1471-4159.2005.03480.x
137. Nadeau S, Rivest S. Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14. J Immunol (2002) 169(6):3370-81.
138. Nadeau S, Rivest S. Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci (2003) 23(13):5536-44.
139. Soulet D, Rivest S. Bone-marrow-derived microglia: myth or reality? Curr Opin Pharmacol (2008) 8(4):508-18. doi:10.1016/j.coph.2008.04.002
140. Frank MG, Miguel ZD, Watkins LR, Maier SF. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav Immun (2010) 24(1):19-30. doi:10.1016/j.bbi.2009.07.008
141. Johnson JD, O'Connor KA, Deak T, Stark M, Watkins LR, Maier SF. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun (2002) 16(4):461-76. doi:10.1006/brbi.2001.0638
142. Johnson JD, O'Connor KA, Hansen MK, Watkins LR, Maier SF. Effects of prior stress on LPS-induced cytokine and sickness responses. Am J Physiol Regul Integr Comp Physiol (2003) 284(2):R422-32.
143. Munhoz CD, Lepsch LB, Kawamoto EM, Malta MB, Lima Lde S, Avellar MC, et al. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci (2006) 26(14):3813-20. doi:10.1523/JNEUROSCI.4398-05.2006
144. de Pablos RM, Villarán RF, Argüelles S, Herrera AJ, Venero JL, Ayala A, et al. Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci (2006) 26(21):5709-19. doi:10.1523/JNEUROSCI.0802-06.2006
145. Espinosa-Oliva AM, de Pablos RM, Villarán RF, Argüelles S, Venero JL, Machado A, et al. Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus. Neurobiol Aging (2011) 32(1):85-102. doi:10.1016/j.neurobiolaging.2009.01.012
146. Frank MG, Watkins LR, Maier SF. Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger. Brain Behav Immun (2013) 33:1-6. doi:10.1016/j.bbi.2013.02.004
147. Blandino P, Barnum CJ, Solomon LG, Larish Y, Lankow BS, Deak T. Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress. Brain Behav Immun (2009) 23(7):958-68. doi:10.1016/j.bbi.2009.04.013
148. Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun (2007) 21(1):47-59. doi:10.1016/j.bbi.2006.03.005
149. García-Bueno B, Madrigal JL, Pérez-Nievas BG, Leza JC. Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. Endocrinology (2008) 149(4):1969-78. doi:10.1210/en.2007-0482
150. Madrigal JL, Hurtado O, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, et al. The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology (2002) 26(2):155-63. doi:10.1016/S0893-133X(01)00292-5
151. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, et al. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology (2003) 28(9):1579-88. doi:10.1038/sj.npp.1300187
152. O'Connor KA, Johnson JD, Hammack SE, Brooks LM, Spencer RL, Watkins LR, et al. Inescapable shock induces resistance to the effects of dexamethasone. Psychoneuroendocrinology (2003) 28(4):481-500. doi:10.1016/S0306-4530(02)00035-5
153. Glezer I, Simard AR, Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience (2007) 147(4):867-83. doi:10.1016/j.neuroscience.2007.02.055
154. Ding Y, Gao ZG, Jacobson KA, Suffredini AF. Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells. J Pharmacol Exp Ther (2010) 335(3):693-702. doi:10.1124/jpet.110.171975
155. Lannan EA, Galliher-Beckley AJ, Scoltock AB, Cidlowski JA. Proinflammatory actions of glucocorticoids: glucocorticoids and TNFa coregulate gene expression in vitro and in vivo. Endocrinology (2012) 153(8):3701-12. doi:10.1210/en.2012-1020
156. Goujon E, Parnet P, Laye S, Combe C, Kelley KW, Dantzer R. Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice. Brain Behav Immun (1995) 9(4):292-303. doi:10.1006/brbi.1995.1028
157. Barnum CJ, Pace TW, Hu F, Neigh GN, Tansey MG. Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge. J Neuroinflammation (2012) 9:9. doi:10.1186/1742-2094-9-9
158. Fantuzzi G, Demitri MT, Ghezzi P. Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone. Clin Exp Immunol (1994) 96(1):166-9. doi:10.1111/j.1365-2249.1994.tb06247.x
159. Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci (2012) 13(1):22-37. doi:10.1038/nrn3138
160. Sorrells SF, Caso JR, Munhoz CD, Sapolsky RM. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron (2009) 64(1):33-9. doi:10.1016/j.neuron.2009.09.032
161. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 4(11):1116-22. doi:10.1038/nn738
162. Herx LM, Rivest S, Yong VW. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol (2000) 165(4):2232-9.
163. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. Interleukin-1beta promotes repair of the CNS. J Neurosci (2001) 21(18):7046-52.